BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27786411)

  • 1. Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma.
    McManus M; Kleinerman E; Yang Y; Livingston JA; Mortus J; Rivera R; Zweidler-McKay P; Schadler K
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel basic helix-loop-helix transcription factor hes4 antagonizes the function of twist-1 to regulate lineage commitment of bone marrow stromal/stem cells.
    Cakouros D; Isenmann S; Hemming SE; Menicanin D; Camp E; Zannetinno AC; Gronthos S
    Stem Cells Dev; 2015 Jun; 24(11):1297-308. PubMed ID: 25579220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
    Tsuru A; Setoguchi T; Matsunoshita Y; Nagao-Kitamoto H; Nagano S; Yokouchi M; Maeda S; Ishidou Y; Yamamoto T; Komiya S
    Br J Cancer; 2015 Mar; 112(7):1232-40. PubMed ID: 25742474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
    Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
    BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
    Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
    Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
    Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
    Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
    Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
    Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
    Tang Q; Lu J; Zou C; Shao Y; Chen Y; Narala S; Fang H; Xu H; Wang J; Shen J; Khokha R
    Oncogene; 2018 Jul; 37(27):3617-3630. PubMed ID: 29610525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Notch Signaling During Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63.
    Ongaro A; Pellati A; Bagheri L; Rizzo P; Caliceti C; Massari L; De Mattei M
    J Cell Physiol; 2016 Dec; 231(12):2652-63. PubMed ID: 26946465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.
    Bai G; Cheung I; Shulha HP; Coelho JE; Li P; Dong X; Jakovcevski M; Wang Y; Grigorenko A; Jiang Y; Hoss A; Patel K; Zheng M; Rogaev E; Myers RH; Weng Z; Akbarian S; Chen JF
    Hum Mol Genet; 2015 Mar; 24(5):1441-56. PubMed ID: 25480889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development.
    De Decker M; Lavaert M; Roels J; Tilleman L; Vandekerckhove B; Leclercq G; Van Nieuwerburgh F; Van Vlierberghe P; Taghon T
    Haematologica; 2021 Jan; 106(1):130-141. PubMed ID: 31919081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.
    Gao Y; Bai L; Shang G
    Aging (Albany NY); 2020 Dec; 13(2):2668-2680. PubMed ID: 33411691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer.
    Yuan R; Ke J; Sun L; He Z; Zou Y; He X; Chen Y; Wu X; Cai Z; Wang L; Wang J; Fan X; Wu X; Lan P
    Clin Exp Metastasis; 2015 Feb; 32(2):169-79. PubMed ID: 25636905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.